These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 602945)

  • 1. Changes in distribution of platelet membrane glycoproteins in patients with myeloproliferative disorders.
    Bolin RB; Okumura T; Jamieson GA
    Am J Hematol; 1977; 3():63-71. PubMed ID: 602945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet membrane glycoprotein abnormalities in myeloproliferative disease.
    Greaves M; Pickering C; Gugliotta L; Preston FE
    Br J Haematol; 1986 Apr; 62(4):780-2. PubMed ID: 3964566
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelets in myeloproliferative disorders. III: Glycoprotein profile in relation to platelet function and platelet density.
    Eche N; Sie P; Caranobe C; Nouvel C; Pris J; Boneu B
    Scand J Haematol; 1981 Feb; 26(2):123-9. PubMed ID: 7256210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal aggregation and increased size of platelets in myeloproliferative disorders.
    Cortelazzo S; Barbui T; Bassan R; Dini E
    Thromb Haemost; 1980 Jun; 43(2):127-30. PubMed ID: 7455970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet abnormalities in myeloproliferative disorders.
    Holme S; Murphy S
    Clin Lab Med; 1990 Dec; 10(4):873-88. PubMed ID: 2272179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating activated platelets in myeloproliferative disorders.
    Wehmeier A; Tschöpe D; Esser J; Menzel C; Nieuwenhuis HK; Schneider W
    Thromb Res; 1991 Feb; 61(3):271-8. PubMed ID: 1709309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelets in the myeloproliferative syndrome.
    Weinfeld A; Branehög I; Kutti J
    Clin Haematol; 1975 Jun; 4(2):373-92. PubMed ID: 1102193
    [No Abstract]   [Full Text] [Related]  

  • 8. Template bleeding time and clinical hemorrhage in myeloproliferative disease.
    Murphy S; Davis JL; Walsh PN; Gardner FH
    Arch Intern Med; 1978 Aug; 138(8):1251-3. PubMed ID: 277084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet unresponsiveness to collagen: involvement of glycoprotein Ia-IIa (alpha 2 beta 1 integrin) deficiency associated with a myeloproliferative disorder.
    Handa M; Watanabe K; Kawai Y; Kamata T; Koyama T; Nagai H; Ikeda Y
    Thromb Haemost; 1995 Mar; 73(3):521-8. PubMed ID: 7667837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Blood platelet function in chronic myeloid-type diseases. I. Myeloproliferative diseases].
    Cieslar P; Matousová O
    Vnitr Lek; 1987 Nov; 33(11):998-1009. PubMed ID: 3439041
    [No Abstract]   [Full Text] [Related]  

  • 11. Blood platelet calcium content and aggregation behaviour in myeloproliferative disorders and secondary thrombocytosis.
    Mindner K; Ostermann G; Hochhaus A; Höche D; Till U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):461-4. PubMed ID: 2465953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional significance of the platelet alpha2-adrenoceptor: studies in patients with myeloproliferative disorders.
    Swart SS; Pearson D; Wood JK; Barnett DB
    Thromb Res; 1984 Mar; 33(5):531-41. PubMed ID: 6326344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet function studies in myeloproliferative disorders.
    Pfliegler G; Boda Z; Udvardy M; Kiss A; Telek B; Pecze K; Nagy P; Rak K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):655-62. PubMed ID: 2435631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic myeloproliferative disorders: improved platelet aggregation following venesection.
    Boughton BJ
    Br J Haematol; 1978 Aug; 39(4):589-98. PubMed ID: 698130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro platelet aggregation defects in patients with myeloproliferative disorders and high platelet counts: are they laboratory artefacts?
    Grignani C; Noris P; Tinelli C; Barosi G; Balduini CL
    Platelets; 2009 Mar; 20(2):131-4. PubMed ID: 19235056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Blood platelet changes in myeloproliferative disorders].
    D'Angelo G; Calvano D; Giardini C
    Minerva Med; 1988 Oct; 79(10):853-7. PubMed ID: 3141845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood platelet and "extra-platelet" serotonin in some myeloproliferative disorders.
    Culebras Poza JM; Launay JM; Briere J; Dreux C
    Biomedicine; 1977 Nov; 27(8):300-3. PubMed ID: 597565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormalities of platelet adenine nucleotides in patients with myeloproliferative disorders.
    Nishimura J; Okamoto S; Ibayashi H
    Thromb Haemost; 1979 Jun; 41(4):787-95. PubMed ID: 483250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a platelet membrane defect in the myeloproliferative syndromes.
    Castaldi PA; Berndt MC; Booth W; Gregory C; Bull H; Greaves M
    Thromb Res; 1982 Sep; 27(5):601-9. PubMed ID: 6960545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormalities of epinephrine-induced platelet aggregation and adenine nucleotides in myeloproliferative disorders.
    Yamamoto K; Sekiguchi E; Takatani O
    Thromb Haemost; 1984 Dec; 52(3):292-6. PubMed ID: 6531753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.